Exelon (EXC) director receives 442 deferred phantom share equivalents
Rhea-AI Filing Summary
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers received a compensation grant of 442 deferred phantom share equivalents of Exelon common stock at a reference price of $46.62 per equivalent. This increased her balance in the Exelon stock fund account under a multi-fund, non-qualified deferred compensation plan to 10,547 phantom share equivalents.
These phantom share equivalents will be settled for cash on a 1-for-1 basis when her service on the board of directors ends. The balance includes 91 additional phantom share equivalents that accrued automatically through dividend reinvestment in the plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred phantom share equivalents | 442 | $46.62 | $21K |
Footnotes (1)
- Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors. Balance includes 91 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.
Key Figures
Key Terms
non-qualified deferred compensation plan financial
automatic dividend reinvestment financial
FAQ
What insider transaction did Exelon (EXC) director Marjorie Rodgers report?
Exelon director Marjorie Rodgers reported receiving 442 deferred phantom share equivalents of Exelon common stock as a compensation grant. These are bookkeeping entries tied to a non-qualified deferred compensation plan rather than currently tradable shares in the market.